Sarcopenia: a chronic complication of type 2 diabetes mellitus

Background Diabetics are at increased risk for impaired mobility and strength, frequently related to the disease control. Sarcopenia is the reduction of muscle mass associated with the decrease in muscle strength and/or performance, resulting in worse morbidity in chronic diseases. Methods The objec...
Ausführliche Beschreibung

Background Diabetics are at increased risk for impaired mobility and strength, frequently related to the disease control. Sarcopenia is the reduction of muscle mass associated with the decrease in muscle strength and/or performance, resulting in worse morbidity in chronic diseases. Methods The objectives of this paper was to assess the prevalence of sarcopenia in patients with type 2 diabetes mellitus (T2DM) and determine its association with diabetes characteristics, progression, and complications, as well as changes in bone mineral density. The sample consisted of patients with T2DM followed at the outpatient clinics of the Serviço de Endocrinologia e Metabologia do Hospital de Clínicas da Universidade Federal do Paraná, from March to August 2016. Participants were men and women above 18 years with T2DM diagnosed at least 1 year earlier. Individuals with chronic diseases, users of any drug that modifies body composition, patients with body mass index (BMI) > 35 or < 18 kg/$ m^{2} $, and users of illicit drugs or hormonal or nutritional supplementation were excluded. The selected patients answered questionnaires about demographics, eating habits, and disease characteristics, and performed a bone densitometry exam in a dual energy absorptiometry (total body; spine and femur (total and neck)), a handgrip test by manual dynamometer, and an evaluation of the abdominal circumference (AC). The medical records were reviewed seeking diabetes data and laboratory test results. Patients were matched for sex, age, and race with healthy controls [Control Group (CG)]. The diagnosis of sarcopenia was conducted according to the criteria of the Foundation for National Institute of Health. Results The final sample consisted of 83 patients in the DG and 83 in the CG. The DG had higher BMI, WC, past history of fractures and lower calcium and healthy diet intake (p < 0.005), compared to the CG. The DG presented a higher frequency of abnormal BMD (osteopenia in 45 (53%), and osteoporosis in 14 (19%)) and comorbidities than the CG (p < 0.005). Pre-sarcopenia was not different between groups, but muscle weakness was present in 25 diabetics (18 women) and only in 5 controls (4 men) (p = 0.00036). Sarcopenia was diagnosed in 13 (16.2%) patients in the DG and 2 (2.4%) in the CG (p = 0.01168). Pre-sarcopenia and sarcopenia were associated with altered BMD (p < 0.005), with no association with diabetes duration or control. Body mass index and osteoporosis increased the likelihood to have sarcopenia, but hypertension and healthy diet decreased it. Conclusion The DG had altered BMD associated with worse glycemic control, and a higher prevalence of sarcopenia, suggesting the need to look for their presence in diabetics. Ausführliche Beschreibung

Autor*in:	Trierweiler, Heloísa [verfasserIn] Kisielewicz, Gabrielle Hoffmann Jonasson, Thaísa Rasmussen Petterle, Ricardo Aguiar Moreira, Carolina Zeghbi Cochenski Borba, Victória

Format:	E-Artikel
Sprache:	Englisch

Erschienen:	2018

Schlagwörter:	Pre-sarcopenia Sarcopenia Type 2 diabetes mellitus Muscle weakness DXA

Anmerkung:	© The Author(s) 2018

Übergeordnetes Werk:	Enthalten in: Diabetology & metabolic syndrome - London : BioMed Central, 2009, 10(2018), 1 vom: 03. Apr.
Übergeordnetes Werk:	volume:10 ; year:2018 ; number:1 ; day:03 ; month:04

Links:	Volltext

DOI / URN:	10.1186/s13098-018-0326-5

Katalog-ID:	SPR030249074